Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study

Mayo Clinic

Status: Enrolling

Conditions: Stage II Bladder Cancer AJCC v8; Stage IIIA Bladder Cancer AJCC v8; Stage 0a Bladder Cancer AJCC v8; Stage I Bladder Cancer AJCC v8; Stage 0is Bladder Cancer AJCC v8

Treatments: Other: Non-Interventional Study

Study type: Observational

Funder types: Other

Identifiers

NCT06350734

NCI-2024-00973 (Registry Identifier)

18-004675 (Other Identifier)

Details and patient eligibility

About

This study evaluates the effect of bladder cancer treatment on quality of life.

Full description

PRIMARY OBJECTIVES:

I. To compare general and disease-specific quality of life outcomes at 6, 12, 24, and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index (BCI) respectively.

II. To identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer.

OUTLINE: This is an observational study.

Patients complete surveys and also have their medical records reviewed on study.

Enrollment: 704 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Have pathologically confirmed, clinically localized, bladder cancer
• Be willing to complete a survey in English before starting definitive treatment (surgery or radiation);
• Able to give consent.

Exclusion criteria

• Does not meet inclusion criteria

Trial design

704 participants in 1 patient group

Observational

Description:

Patients complete surveys and also have their medical records reviewed on study.

Treatment:

Other: Non-Interventional Study